Minnesota Cancer Patients Report Symptom Relief After Joining Medical Cannabis Program

For someone living with cancer, a better night’s sleep or a little less nausea can make a real difference. A new report from Minnesota’s Office of Cannabis Management gives us a closer look at what patients experienced after joining the state’s medical cannabis program.

National NORML brought this research to our attention in its original article. Their team has spent decades making cannabis research and policy developments accessible to the public, and we encourage you to read their coverage alongside this summary.

What did the Minnesota report find?

The Minnesota Office of Cannabis Management report examined 6,621 patients with a cancer-related qualifying condition who purchased medical cannabis through the state program between 2015 and 2023. Patients rated symptoms such as pain, nausea, vomiting, anxiety, depression, appetite, fatigue, and sleep over time.

Among patients who began with moderate to severe symptoms, the share reporting at least a 30% reduction within four months of their first purchase included:

Symptom	Patients reporting at least a 30% reduction
Pain	29.9%
Lack of appetite	38.2%
Nausea	39.9%
Vomiting	47.2%

The report also found decreases in anxiety and depression scores and improved sleep scores within four months. These figures describe patients’ reported experiences; they do not mean every patient received relief.

What about side effects?

About 15% of patients reported a side effect. Of the side effects reported, 60% were rated mild, 34% moderate, and 6.2% severe. Dry mouth was the most commonly reported side effect overall. The authors also cautioned that their records may miss side effects experienced by patients who stopped purchasing cannabis.

What does this mean for cancer care?

This was an analysis of patients’ experiences in a medical cannabis program, not a randomized clinical trial. It cannot establish that cannabis caused every improvement, and it does not show that cannabis treats or cures cancer. The report also notes substantial loss to follow-up and says the program did not collect information about patients’ cancer treatments. Those limits matter when interpreting the results.

What the findings do show is that many patients reported meaningful symptom relief while participating in a regulated medical cannabis program. That is worth studying carefully and discussing honestly, especially when the symptoms involved can shape a person’s daily quality of life.

Read National NORML’s original article on the Minnesota findings for its reporting, then explore the full state report for the methods and detailed results. If you or someone you love is undergoing cancer treatment, talk with the treating care team before making changes to symptom management.